A COMPREHENSIV REVIEW ON ANALYTICAL METHODS FOR ESTIMATION OF DEXTROMETHORPHAN HYDROBROMIDE AND MEMANTINE HYDROCHLORIDE
Main Article Content
Keywords
Dextromethorphan Hydrobromide (DXM HBr); Memantine Hydrochloride (MEM HCl); Neuroprotection; NMDA receptor antagonists; Spectrophotometry: RP-HPLC; LC-MS/MS: Analytical method development; Method validation (ICH Q2(R1)); Simultaneous estimation; Stability-indicating methods;
Abstract
Dextromethorphan hydrobromide (DXM HBr) and memantine hydrochloride (MEM HCl) are two pharmacologically significant central nervous system (CNS) agents that have attracted considerable interest due to their neuroprotective potential. DXM, a dextrorotatory morphinan derivative, is primarily used as a non-opioid antitussive but also exhibits uncompetitive N-methyl-D-aspartate (NMDA) receptor antagonism and sigma-1 receptor agonism, positioning it as a candidate in epilepsy, neuropathic pain, and neurodegenerative disorders. MEM HCl, a low-to-moderate affinity NMDA receptor antagonist, selectively blocks pathological glutamatergic excitotoxicity while preserving physiological neurotransmission, making it an approved therapy for moderate to severe Alzheimer’s disease. The combination of DXM and MEM has been explored for synergistic neuroprotection, further emphasizing the need for reliable analytical methodologies. Over the past two decades, a variety of analytical approaches—including spectrophotometry, chromatography (TLC, HPLC, UPLC, GC), hyphenated techniques (LC-MS/MS, GC-MS), electrochemical methods, and capillary electrophoresis—have been developed for their individual and simultaneous quantification in pharmaceutical formulations and biological matrices. Among these, RP-HPLC and LC-MS/MS remain the most widely adopted, offering stability-indicating capability and ultra-sensitive detection, respectively. Method validation in line with ICH Q2(R1) ensures analytical reliability, covering accuracy, precision, linearity, specificity, and robustness. Emerging trends in green analytical chemistry, high-throughput analytical systems, and miniaturized lab-on-a-chip platforms are reshaping the field, focusing on sustainability, efficiency, and regulatory adaptability. This review provides a comprehensive overview of analytical strategies for DXM and MEM, highlighting their clinical importance, methodological challenges, and future perspectives in advanced pharmaceutical and bioanalytical sciences.
References
2. Parsons C. G., Stöffler A., Danysz W., “Memantine: A NMDA receptor antagonist that improves memory by restoring homeostasis in the glutamatergic system." CNS Drugs,2007; 21(11); 877–901.
3. Cummings J. L., Lyketsos C. G., Peskind E. R., Porsteinsson A. P., Mintzer J. E., Scharre D. W., DeBrota D. J., “Effect of dextromethorphan–quinidine on agitation in patients with Alzheimer’s disease dementia.” JAMA, 2019; 318(5); 478–488.
4. Shah J., Patel N., Patel H., “Development and validation of RP-HPLC method for simultaneous estimation of memantine hydrochloride and donepezil hydrochloride in tablet dosage form.” Journal of Pharmaceutical Sciences and Bioscientific Research, 2019; 9(5); 247–252.
5. Blessy M, Patel RD, Prajapati PN, Agrawal YK., “Development of forced degradation and stability-indicating methods—A critical review”. J Pharm Anal, 2014; 4(3); 159–165.
6. Abdelwahab N. S., Bedair M. M., Farid N. F., “Development and validation of HPLC and spectrophotometric methods for simultaneous determination of memantine hydrochloride and other drugs.” Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2021; 252; 1194-1293.
7. Nirogi R., Kandikere V., Shukla M., Mudigonda K., Maurya S., Boosi, R., “Sensitive and selective LC–MS/MS method for quantification of dextromethorphan and dextrorphan in human plasma.” Journal of Chromatography, 2008: 870(1); 132–140.
8. Bedair M. M., Abdelwahab N. S., Farid N. F., “Validated spectrofluorimetric methods for determination of memantine hydrochloride in pharmaceutical dosage forms.” Luminescence, 2020; 35(4); 481–489.
9. Rao R. N., Bompelli D., Maurya P. K., “Simultaneous determination of memantine and donepezil in human plasma by HPTLC method.” Biomedical chromatography, 2014: 28(7); 934-940.
10. De Moraes N. V., “Development and validation of a UPLC–MS/MS method for determination of memantine in human plasma.” Journal of Pharmaceutical and Biomedical Analysis, 2014; 100; 295–301.
11. Zou Y., “Gas chromatographic determination of memantine in human plasma with flame ionization detection.” Journal of Chromatography B, 2006; 844(2); 329–334.
12. Chaves A. R., “A highly sensitive LC–MS/MS method for quantification of memantine in plasma and cerebrospinal fluid.” Bioanalysis, 2019; 11(18); 1653–1663.
13. Meatherall R., “GC–MS confirmation of dextromethorphan and dextrorphan in serum and urine.” Journal of Analytical Toxicology, 2004; 28(8); 628–631.
14. Shamsipur M., Soleymanpour A., Tangestaninejad S., “PVC membrane electrodes for potentiometric determination of dextromethorphan.” Analytica Chimica Acta, 2002; 462(1); 65–72.
15. Gholivand M. B., Torkashvand M., “Memantine potentiometric sensor based on molecularly imprinted polymers.” Sensors and Actuators B: Chemical, 2012; 162(1); 102–108.
16. Zhang Y., “Determination of memantine in rat plasma by capillary electrophoresis with laser-induced fluorescence detection.” Journal of Pharmaceutical and Biomedical Analysis, 2010; 53(5); 1254–1258.
17. “Dextromethorphan hydrobromide” The Indian Pharmacopeia. Volume II, 2022, pp. 2063
18. “Dextromethorphan hydrobromide”, United State Pharmacopoeia, 2025
19. Vineeta K., Rupali K., “development and validation of simple UV spectrophotometric method for the estimation of dextromethorphan hydrobrominr in bulk and marketed dosage formulation” International Journal of Pharmaceutical Sciences and Drug Research, 2016; 8(3); 170-173.
20. Santosh V. Gandhi, Shubhangi K. Dyandyan, “Development and validation of stability indicating HPTLC method for estimation of dextromethorphan hydrobromide” journal of Applied Pharmaceutical Research Volume 2017; 5(3); 27–33.
21. Ayman ouda, Ragga El-sheikh, Zeineb El Shafey, Nagda Hossny, Rham El-Azzary, “Spectrophotometric Determination of Pipazethate HCl and Dextromethorphan HBr using Potassium Permanganate” int J Biomed Sci. 2008; 4(4); 294-302.
22. V Tantishaiyakul, C Poeaknapo, P Sribun, K Sirisuppanon., “Simultaneous determination of dextromethorphan HBr and bromhexine HCl in tablets by first-derivative spectrophotometry” J Pharm Biomed Anal 1998; 17(2); 237-243.
23. “Memantine Hydrochloride”, The Indian Pharmacopeia, Volume Ⅱ, 2022, pp 2850.
24. “Memantine Hydrochloride”, United State Pharmacopoeia, Volume 39, date: 2/15/25
25. Tukaram B Sawant, Dhananjay V Mane, “To Develop HPLC Method for the Assay of Memantine Hydrochloride Tablets Using Refractive Index (Ri) Detector.” IAJPS, 2017; 4 (11); 4391-4397.
26. Sergio del Rio-Sancho, César E. SernaJiménez, “High-Performance Liquid Chromatographic Ultraviolet Determination of Memantine Hydrochloride after In Vitro Transdermal Diffusion Studies” Journal of Chemistry, 2013; 7
27. Kaur et al., Journal of Pharmaceutical Research, 2011.
28. Ayesha Anees, Asra Ali Bahazeq, MD. Muzaffar-Ur-Rehman, Syed Akbar, Juveria Mehveen., “Development and Validation of Memantine Hydrochloride by RP-HPLC Method.” Asian J. Pharm. Res. 2019; 9(2); 69-74.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Vivek Gelani
Student, Khyati College of Pharmacy, Gujarat Technological University
Ms. Purvi Ramanuj
Khyati College of Pharmacy, Ahmedabad, Gujarat
Dr. Pragnesh Patani
Principal, Khyati College of Pharmacy, Gujarat Technological University, Ahmedabad, Gujarat, India.